CHU Henri Mondor

creteil 6 trials 2 recruiting

6 Registered trials

2 Currently recruiting

Organisation

CHU Henri Mondor

Location

creteil, France

Identifier

ORL-000009640

Address

51 avenue du marechal de Lattre de Tassigny, 94000, France

Departments

Gastroenterology
hematologie
Medical oncology
Oncology

Clinical trials at this site (6)

Search interface

Two Combination Treatment Regimens of Nivolumab and Ipilimumab in Patients With dMMR and / or MSI mCRC. (NIPISAFE) Pending

2024-518138-10-00 Patients with DMMR and/or MSI metastatic colorectal can 4
Maintenance With OSE2101 Plus FOLFIRI, or FOLFIRI After FOLFIRINOX-based Induction Therapy in Locally Advanced or Metastatic Pancreatic Duct… Pending

2024-518139-12-00 locally advanced or metastatic Pancreatic ductal adenoc 4
MAINTAIN-POP: EXL01 and prevention of post-operative recurrence of Crohn's disease Recruiting

2024-511357-22-00 Crohn's disease 4 2025-03-31
PRODIGE 70 - CIRCULATE - CIRCULATING TUMOR DNA BASED DECISION FOR ADJUVANT TREATMENT IN COLON CANCER STAGE II Recruiting

2024-515297-27-00 colon carcinoma 5 2024-08-14
A Study to Learn About the Study Medicine Called PF-07220060 in Combination With Letrozole in People Over 18 Years of Age With HR-Positive, … Ended

2024-512925-95-00 Advanced/Metastatic Breast Cancer 5 2025-05-16
PREVENE : Preemptive therapy with Venetoclax for high risk CLL stage A patients, a phase II trial of the FILO Ended

2024-513718-37-00 IGHV unmutated patients with high-risk stage A CLL feat 4 2024-08-01